During the past decade, National Capital Clinical Research Consortium conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Capital Clinical Research Consortium" #1 collaborator was "Bayer" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator and "Celgene" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "National Capital Clinical Research Consortium" are "Metastatic Breast Cancer" (4 trials), "Breast Cancer" (3 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Extensive-Stage Small Cell Lung Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "National Capital Clinical Research Consortium" in a lesser frequency.

Most popular intervention types in "National Capital Clinical Research Consortium" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (7 trials), "Ixabepilone" (3 trials), "Rituximab" (3 trials), "Sorafenib" (3 trials) and "Amrubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Capital Clinical Research Consortium" are 10 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "National Capital Clinical Research Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in National Capital Clinical Research Consortium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Capital Clinical Research Consortium, 4 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".